Upconversion nanoparticles–based targeted imaging of MCF-7 breast cancer cells
Source abstract
Abstract
Upconversion nanoparticles (UCNPs) doped with lanthanides are introduced as a significant tool in bioimaging applications. Here in, a comparative study has been performed to understand the cell internalization capacity of folic acid (FA) and arginine-glycine-aspartic acid-lysine (RGDK) ligands. To achieve this goal, polyacrylic acid (PAA) coated UCNPs (NaYF4:Yb3+, Er3+) are conjugated with various surface ligands such as FA and RGDK through a straightforward ligand exchange procedure. Ligand conjugation to UCNPs was characterized with a transmission electron microscope (TEM), Fourier-transform infrared (FT-IR) spectroscopy, zeta potential measurements, nuclear magnetic resonance (NMR) spectroscopy, and NanoDrop measurements. The cellular uptake of the nanoparticles was investigated on the breast cancer MCF-7 cell line. The obtained results demonstrated that folic acid and RGDK functionalized UCNPs showed remarkably higher cellular uptake, which clearly indicates that the specific targeting of UCNPs provides a better quality of sub-cellular imaging at lower energy band region.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. Ghomi M, Zare EN, Alidadi H et al (2023) A multifunctional bioresponsive and fluorescent active nanogel composite for breast cancer therapy and bioimaging. Adv Compos Hybrid Mater 6:51. https://doi.org/10.1007/s42114-022-00613-010.1007/s42114-022-00613-0 ↗
2. Phuong HT, Huong TT, Vinh LT, Hoang TK et al (2019) Synthesis and characterization of NaYF4:Yb3+, Er3+@Silica-N=folic acide nanocomplex for bioimaginable detecting MCF-7 breast cancer cells. J Rare Earths 37:1183–1187. https://doi.org/10.1016/j.jre.2019.01.00510.1016/j.jre.2019.01.005 ↗
3. Cho SK, Su LJ, Mao C, Wolenski CD, Flaig TW, Park W (2019) Multifunctional nanoclusters of NaYF4:Yb3+, Er3+ upconversion nanoparticle and gold nanorod for simultaneous imaging and targeted chemotherapy of bladder cancer. Mater Sci Eng, C 97:784–792. https://doi.org/10.1016/j.msec.2018.12.11310.1016/j.msec.2018.12.113 ↗
4. Zhengze Y, Yegang G, Qiaoqiao S, Wei P, Xiuyan W, Na L, Bo T (2018) A pre-protective strategy for precise tumor targeting and efficient photodynamic therapy with a switchable DNA/upconversion nanocomposite. Chem Sci 9(14):3563–3569. https://doi.org/10.1039/c8sc00098k10.1039/c8sc00098k ↗
5. Bernard PS (2013) Breast Cancer. In: Ginsburg SG (ed) Genomic and Personalized Medicine, 2nd edn. Academic Press, Cambridge, pp 707–71310.1016/B978-0-12-382227-7.00060-4 ↗
6. Soule HD, Vazquez J, Long A, Albert S, Brennan M (1973) A human cell line from a pleural effusion derived from a breast carcinoma 2. JNCI: J Natl Cancer Inst 51(5):1409–1416. https://doi.org/10.1093/jnci/51.5.140910.1093/jnci/51.5.1409 ↗
7. Toy R, Bauer L, Hoimes C, Ghaghada KB, Karathanasis E (2014) Targeted nanotechnology for cancer imaging. Adv Drug Deliv Rev 76:79–97. https://doi.org/10.1016/j.addr.2014.08.00210.1016/j.addr.2014.08.002 ↗
8. Polikarpov D, Liang L, Care A, Sunna A, Campbell D, Walsh B, Balalaeva I, Zvyagin A, Gillatt D, Guryev E (2019) Functionalized upconversion nanoparticles for targeted labelling of bladder cancer cells. Biomolecules 9(12):820. https://doi.org/10.3390/biom912082010.3390/biom9120820 ↗
9. Oseledchyk A, Andreou C, Wall MA, Kircher MF (2017) Folate-targeted surface-enhanced resonance raman scattering nanoprobe ratiometry for detection of microscopic ovarian cancer. ACS Nano 11(2):1488–1497. https://doi.org/10.1021/acsnano.6b0679610.1021/acsnano.6b06796 ↗
10. Wang JB, Jun D, Chen-Jie F, Xiaoyuan C (2017) TAT-modified gold nanoparticle carrier with enhanced anticancer activity and size effect on overcoming multidrug resistance. ACS Appl Mater Interfaces 9(7):5828–5837. https://doi.org/10.1021/acsami.6b1520010.1021/acsami.6b15200 ↗
11. Danhier F, Le Breton A, Préat V (2012) RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol Pharm 9(11):2961–2973. https://doi.org/10.1021/mp300273310.1021/mp3002733 ↗
12. Lao YH, Phua KKL, Leong KW (2015) Aptamer Nanomedicine for cancer therapeutics: barriers and potential for translation. ACS Nano 9(3):2235–2254. https://doi.org/10.1021/nn507494p10.1021/nn507494p ↗
13. Kobayashi H, Turkbey B, Watanabe R, Choyke PL (2014) Cancer drug delivery: considerations in the rational design of nanosized bioconjugates. Bioconjug Chem 25(12):2093–2100. https://doi.org/10.1021/bc500481x10.1021/bc500481x ↗
14. Buckley CD, Pilling D, Henriquez NV et al (1999) RGD peptides induce apoptosis by direct caspase-3 activation. Nature 397:534–539. https://doi.org/10.1038/1740910.1038/17409 ↗
15. Desgrosellier JS, Cheresh DA (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10:9–22. https://doi.org/10.1038/nrc274810.1038/nrc2748 ↗
16. Cai W, Shin DW, Chen K et al (2006) Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett 6:669–676. https://doi.org/10.1021/nl052405t10.1021/nl052405t ↗
17. Lee HY, Li Z, Chen K et al (2008) PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J Nucl Med 49:1371–1379. https://doi.org/10.2967/jnumed.108.05124310.2967/jnumed.108.051243 ↗
18. Benezra M, Penate-Medina O, Zanzonico PB et al (2011) Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest 121:2768–2780. https://doi.org/10.1172/JCI4560010.1172/JCI45600 ↗
19. Kim YH, Jeon J, Hong SH et al (2011) Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125. Small 7:2052–2060. https://doi.org/10.1002/smll.20110092710.1002/smll.201100927 ↗
20. Shaoshan S, Zhurong M, Guizhen T, Hongli W, Xiang C, Deshmukh HA (2021) PAA modified upconversion nanoparticles for highly selective and sensitive detection of Cu2+ ions. Front Chem 8:2296–2646. https://doi.org/10.3389/fchem.2020.61976410.3389/fchem.2020.619764 ↗
21. Jia F, Li G, Yang B, Yu B, Shen Y, Cong H (2019) Investigation of rare earth upconversion fluorescent nanoparticles in biomedical field. Nanotechnol Rev 8(1):1–17. https://doi.org/10.1515/ntrev-2019-000110.1515/ntrev-2019-0001 ↗
22. Rinkel T, Raj AN, Dühnen S, Haase M (2015) Synthesis of 10 nm β-NaYF4:Yb, Er/NaYF4 core/shell upconversion nanocrystals with 5 nm particle cores. Angew Chem Int Ed 55:116. https://doi.org/10.1002/anie.20150883810.1002/anie.201508838 ↗
23. Chavez-Garcia D, Juárez-Moreno K, Campos CH, Alderete JB, Hirata GA (2017) Upconversion rare earth nanoparticles functionalized with folic acid for bioimaging of MCF-7 breast cancer cells. J Matter Res 33(2):191–200. https://doi.org/10.1557/jmr.2017.46310.1557/jmr.2017.463 ↗
24. Wang X, Xu T, Bua Y, Yan X (2016) Giant enhancement of upconversion emission in NaYF4:Er3+@NaYF4:Yb3+ active-core/active-shell nanoparticles. RSC Adv 6(27):22845–22851. https://doi.org/10.1039/C5RA25826J10.1039/C5RA25826J ↗
25. MacKenzie LE, Goode JA, Vakurov A, Nampi PP, Saha S, Jose G, Millner PA (2018) The theoretical molecular weight of NaYF4:RE photonic upconversion nanoparticles. Sci Rep 8:1106–1117. https://doi.org/10.1038/s41598-018-19415-w10.1038/s41598-018-19415-w ↗
26. Li Z (2015) Hydrothermal synthesis of hydrophilic NaYF4:Yb, Er nanoparticles with bright upconversion luminescence as biological label. Mater Lett 139:22–25. https://doi.org/10.1016/j.matlet.2014.10.04210.1016/j.matlet.2014.10.042 ↗
27. Tian G, Zheng XP, Zhang X, Yin WY, Yu J, Wang DL (2015) TPGS-stabilized NaYbF4: Er Upconversion nanoparticles for dual-modal fluorescent/CT imaging and anticancer drug delivery to overcome multi-drug resistance. Biomaterials. 40:107–116. https://doi.org/10.1016/j.biomaterials.2014.11.02210.1016/j.biomaterials.2014.11.022 ↗
28. Liang XH, Fan J, Zhao YY, Cheng M, Wang XJ, R. Jin RY, et al (2017) A targeted drug delivery system based on folic acid - functionalized upconversion luminescent nanoparticles. J Biomater Appl 31(9):1247–1256. https://doi.org/10.1177/088532821770128910.1177/0885328217701289 ↗
29. Pan Y, Yang J, Luan X, Liu X, Li X, Yang J, Song Y (2019) Near-infrared upconversion–activated CRISPR-Cas9 system: a remote-controlled gene editing platform. Sci Adv 5(4):eaav7199. https://doi.org/10.1126/sciadv.aav719910.1126/sciadv.aav7199 ↗
30. Odularu AT (2018) Metal nanoparticles: thermal decomposition, biomedicinal applications to cancer treatment, and future perspectives. Bioinorg Chem Appl 2018:1–6. https://doi.org/10.1155/2018/935470810.1155/2018/9354708 ↗
31. Gorris HH, Sedlmeier A (2015) Surface modification and characterization of photon-upconverting nanoparticles for bioanalytical applications. Chem Soc Rev 44(6):1526–1560. https://doi.org/10.1039/c4cs00186a10.1039/c4cs00186a ↗
32. Lim K, Kim HK, Le XT, Nguyen NT, Lee ES, Oh KT, Youn YS (2020) Highly red light-emitting erbium- and lutetium-doped core-shell upconverting nanoparticles surface-modified with PEG-folic acid/TCPP for suppressing cervical cancer HeLa cells. Pharmaceutics 12(11):1102–1119. https://doi.org/10.3390/pharmaceutics1211110210.3390/pharmaceutics12111102 ↗
33. Yi GS, Chow GM (2006) Synthesis of hexagonal-phase NaYF4: Yb, Er and NaYF4: Yb, Tm nanocrystals with efficient up-conversion fluorescence. Adv Func Mater 16(18):2324–232910.1002/adfm.200600053 ↗
34. Liang L, Everest-Dass AV, Kostyuk AB, Khabir Z, Zhang R, Trushina DB, Zvyagin AV (2022) The surface charge of polymer-coated upconversion nanoparticles determines protein corona properties and cell recognition in serum solutions. Cells 11:3644. https://doi.org/10.3390/cells1122364410.3390/cells11223644 ↗
35. Chávez-García D, Juarez-Moreno K, Campos CH, Tejeda EM, Alderete JB, Hirata GA (2018) Cytotoxicity, genotoxicity and uptake detection of folic acid-functionalized green upconversion nanoparticles Y2O3/Er3+, Yb3+ as biolabels for cancer cells. J Mater Sci 53(9):6665–6680. https://doi.org/10.1007/s10853-017-1946-010.1007/s10853-017-1946-0 ↗
36. Zhou A, Wei Y, Wu B, Chen Q, Xing D (2012) Pyropheophorbide A and c (RGDyK) comodified chitosan-wrapped upconversion nanoparticle for targeted near-infrared photodynamic therapy. Mol Pharm 9(6):1580–1589. https://doi.org/10.1021/mp200590y10.1021/mp200590y ↗
37. Voronovic E, Skripka A, Jarockyte G, Ger M, Kuciauskas D, Kaupinis A, ... , Karabanovas V (2021) Uptake of upconverting nanoparticles by breast cancer cells: surface coating versus the protein corona. ACS Appl Mater Interfaces 13(33):39076–3908710.1021/acsami.1c10618 ↗